Edition:
United Kingdom

Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

10.57USD
18 Oct 2018
Change (% chg)

$-0.35 (-3.21%)
Prev Close
$10.92
Open
$10.91
Day's High
$11.09
Day's Low
$10.49
Volume
63,300
Avg. Vol
98,337
52-wk High
$12.86
52-wk Low
$5.25

Chart for

About

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests,... (more)

Overall

Beta: 1.93
Market Cap(Mil.): $312.50
Shares Outstanding(Mil.): 33.89
Dividend: --
Yield (%): --

Financials

  VCYT.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -0.80 -- --
ROI: -36.37 0.58 14.30
ROE: -62.64 1.62 16.03

BRIEF-Veracyte Files For Mixed Shelf Of Up To $125 Million

* VERACYTE INC FILES FOR MIXED SHELF OF UP TO $125 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2jlv3GH) Further company coverage:

01 May 2018

BRIEF-Veracyte Q1 Loss Per Share $0.27

* Q1 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S

01 May 2018

Earnings vs. Estimates